ACL Reconstruction With/Without ALL Reconstruction

Sponsor
Centre of Postgraduate Medical Education (Other)
Overall Status
Recruiting
CT.gov ID
NCT05461625
Collaborator
(none)
762
1
3
39
19.5

Study Details

Study Description

Brief Summary

This study will compare Anterior Cruciate Reconstruction with or without Anterolateral Ligament Reconstruction in patients with ACL injury. The purpose of this study is evaluate if addition of ALLr to ACLr provides better clinical, radiological and laboratory outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ACL reconstruction
  • Other: ALL anatomic
  • Other: ALL tenodesis
N/A

Detailed Description

This study compare ACL reconstruction and additional tenodesis or ALL recontruction described by Arnold. Patients will be randomized fot this tree group and surgeon will be blinded.

Anterolateral ligament reconstruction could play a role in augmenting rotational stability in the ACL-reconstructed knee and are most likely to benefit hyperlax patients, revision cases, pivoting athletes, and those with IKDC grade III pivot shifts. In our study we will would like to confirm this hypothesis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
762 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Prospective, Randomized, Double Blinded Trial Comparing Clinical, Radiological and Laboratory Outcomes of Anterior Cruciate Ligament Reconstruction With or Without Concomitant AnteroLateral Ligament Reconstruction.
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: ACL

Anterior cruciate ligament reconstruction without additional procedure

Procedure: ACL reconstruction
Anterior cruciate ligament reconstruction

Active Comparator: ACL + ALL anatomic

Anterior cruciate ligament reconstruction and anatomic anterolateral ligament reconstruction

Procedure: ACL reconstruction
Anterior cruciate ligament reconstruction

Other: ALL anatomic
anatomic anterolateral ligament reconstruction

Active Comparator: ACL + ALL tenodesis

Anterior cruciate ligament reconstruction and anterolateral ligament tenodesis

Procedure: ACL reconstruction
Anterior cruciate ligament reconstruction

Other: ALL tenodesis
anterolateral ligament teondesis

Outcome Measures

Primary Outcome Measures

  1. Knee stability [24 months]

    KT-1000 assesment for knee stability

Secondary Outcome Measures

  1. Functional tests [12 months]

    hop-for-distance

  2. KOOS (Knee injury and Osteoarthritis Outcome Score) [6 weeks]

    Knee Injury and Osteoarthritis Outcome Score; KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability. In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89 and the QOL subscale from 0.83-0.95. In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92 and the QOL subscale from 0.6-0.91 (4).

  3. KOOS (Knee injury and Osteoarthritis Outcome Score) [6 months]

    Knee Injury and Osteoarthritis Outcome Score; KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability. In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89 and the QOL subscale from 0.83-0.95. In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92 and the QOL subscale from 0.6-0.91 (4).

  4. KOOS (Knee injury and Osteoarthritis Outcome Score) [24 months]

    Knee Injury and Osteoarthritis Outcome Score; KOOS is intended to be used for knee injury that can result in post traumatic osteoarthritis (OA); KOOS has high test-retest reliability. In patients with knee injury, ICCs for the Pain subscale range from 0.85-0.93, the Symptoms subscale from 0.83-0.95, the ADL subscale from 0.75-0.91, the Sport/Rec subscale from 0.61-0.89 and the QOL subscale from 0.83-0.95. In patients with knee OA, ICCs for the Pain subscale range from 0.8-0.97, the Symptoms subscale from 0.74-0.94, the ADL subscale from 0.84-0.94, the Sport/Rec subscale from 0.65-0.92 and the QOL subscale from 0.6-0.91 (4).

  5. Tegner Lysholm Knee Scoring Scale [6 weeks]

    The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability).

  6. Tegner Lysholm Knee Scoring Scale [6 months]

    The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability).

  7. Tegner Lysholm Knee Scoring Scale [24 months]

    The Lysholm Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability).

  8. IKDC (International Knee Documentation Committee) subjective knee evaluation [6 weeks]

    IKDC is subjective scale that provides patients with an overall function score. Total to a scaled number ranges from 0 to 100. highr number representing higher levels of function.

  9. IKDC (International Knee Documentation Committee) subjective knee evaluation [6 months]

    IKDC is subjective scale that provides patients with an overall function score. Total to a scaled number ranges from 0 to 100. highr number representing higher levels of function.

  10. IKDC (International Knee Documentation Committee) subjective knee evaluation [24 months]

    IKDC is subjective scale that provides patients with an overall function score. Total to a scaled number ranges from 0 to 100. highr number representing higher levels of function.

  11. SF-36 (36-Item Short Form Survey) [6 weeks]

    Quality of life

  12. SF-36 (36-Item Short Form Survey) [6 months]

    Quality of life

  13. SF-36 (36-Item Short Form Survey) [24 months]

    Quality of life

  14. VAS (Visual analog scale) [6 weeks]

    The pain VAS is a unidimensional measure of pain intensity. The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).

  15. VAS (Visual analog scale) [6 months]

    Pain Visual Analog Scale The pain VAS is a unidimensional measure of pain intensity. The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).

  16. VAS (Visual analog scale) [24 months]

    Pain Visual Analog Scale The pain VAS is a unidimensional measure of pain intensity. The most simple VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (symptom, pain, health)[8] orientated from the left (worst) to the right (best).

  17. KOOS PF (Knee injury and Osteoarthritis Outcome Score Patellofemoral) [6 weeks]

    the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA. This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability

  18. KOOS PF (Knee injury and Osteoarthritis Outcome Score Patellofemoral) [6 months]

    the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA. This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability

  19. KOOS PF (Knee injury and Osteoarthritis Outcome Score Patellofemoral) [24 months]

    the 'Knee Injury and Osteoarthritis Outcome Score Patellofemoral' questionnaire (KOOS-PF) is frequently used to measure symptoms and function among the people with PFJ-OA. This scale is scored from 0 to 100, with 100 representing no disability and 0 representing maximum disability

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • primary ACL injury
Exclusion Criteria:
  • no informed consent to participate in the study

  • age under 18 years or above 65

  • multilligament injury or single plane knee instability (medial, lateral)

  • another musculoskeletal disorders in lower limb

  • lower limb deformity requiring axis correction below 4o or above 12.5o

  • joints inflammatory diseases

  • ASA score > II

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Orthopaedics and Traumatology, Centre of Postgraduate Medical Education, Professor A. Gruca Teaching Hospital Otwock Mazowieckie Poland 05-400

Sponsors and Collaborators

  • Centre of Postgraduate Medical Education

Investigators

  • Study Chair: Rafal Kaminski, SPSK CMKP

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rafał Kamiński, Professor CMKP, Centre of Postgraduate Medical Education
ClinicalTrials.gov Identifier:
NCT05461625
Other Study ID Numbers:
  • ACL_ALL
First Posted:
Jul 18, 2022
Last Update Posted:
Jul 18, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rafał Kamiński, Professor CMKP, Centre of Postgraduate Medical Education
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2022